CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping...
Vous n'êtes pas connecté
CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, with a “chimeric antigen receptor” (CAR) enables them to specifically recognise and attack cancer cells. CAR T cell therapy has demonstrated its potential by [...]
CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping...
Researchers from Mass General Brigham, the Broad Institute of MIT and Harvard, USA, have identified genetic modifications that can improve the...
Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s genetic...
Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s genetic...
ADSCC, Yas Clinic pioneer CAR-T cell therapy for life-threatening lupus, antiphospholipid syndrome Abu Dhabi Stem Cells Centre (ADSCC), in...
Cancer treatment resistance, a significant challenge, arises when cancer cells adapt to therapy through genetic mutations, drug expulsion, or...
BAVINA SOOKDEO September is Sickle Cell Awareness Month and consultant physician Dr Camilo Humphrey, who has a special interest in transfusion...
In tissue biopsies, cancer cells are frequently observed to have nuclei (the cell's genetic information storage) larger than normal.
Scientists have developed a genetic "Trojan horse" therapy that targets and kills cancer cells tied to Kaposi's sarcoma, with fewer side effects.
Huntington's disease is an inherited genetic disease, causing progressive damage to certain nerve cells in the brain. This damage worsens over time...